Heart Disease News and Research

Latest Heart Disease News and Research

New findings on macrophage activation can facilitate development of early diagnosis tools

Immune system cells called macrophages spring into action to surround and destroy threats such as viruses or cancer cells. But sometimes the would-be protective response leads to persistent inflammation, which, in turn, can cause disease.Scientists don't know exactly how macrophages cross the line from being good cops to bad cops, but researchers at the University of Florida recently unearthed several clues about the mechanisms involved. Through the lens of two inflammation-related diseases, HIV and rheumatoid arthritis, they identified changes in specific proteins linked to the action of macrophages, white blood cells that are key to the body's natural defenses.

16 Jul 2010

ACTOS offers safety profile regarding risk of CV events in people with type 2 diabetes: Takeda

The U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting primarily focused on reviewing the cardiovascular safety of rosiglitazone, as presented by the FDA and GlaxoSmithKline. Following this two day discussion, Takeda Pharmaceuticals North America, Inc. ("Takeda") underscores its position that ACTOS (pioglitazone HCl) offers an established safety profile regarding the risk of CV events in people living with type 2 diabetes.

16 Jul 2010

Glaxo announces a $2.3 billion in legal liability charges

British pharmaceutical giant GlaxoSmithKline, announced this Thursday that its second-quarter charges related to legal cases involving the two drugs Avandia (diabetes drug) and Paxil (drug for anxiety and depression) would run up to $2.36 billion. Avandia’s use and its potential risk of causing heart problems were being debated this week by an advisory panel to the US Food & Drugs Administration (FDA).

16 Jul 2010

Scientists gather to discuss latest advances in Alzheimer's disease at AAICAD 2010

This week, nearly 4,000 scientists from around the world gathered to report and discuss the latest advances in research on treatments, risk factors, and diagnosis for the health epidemic of the 21st century – Alzheimer's disease – at the Alzheimer's Association's 2010 International Conference on Alzheimer's Disease in Honolulu.

15 Jul 2010

Practice Fusion API Challenge kicked off

Practice Fusion, the free, web-based Electronic Health Record company, kicked off the Practice Fusion API Challenge today as part of the Health 2.0 Developer Challenge, an initiative supported by the US Department of Health and Human Services. The challenge invites developers to connect patient health data from medical devices, mobile apps, social media systems and websites to doctors in real-time through Practice Fusion's new API.

15 Jul 2010

National Jewish Health named #1 respiratory hospital in the nation

For the 13th consecutive year, National Jewish Health has been named the #1 respiratory hospital in the nation by U.S. News & World Report.

15 Jul 2010

Sepracor to change name to Sunovion Pharmaceuticals

Sepracor Inc. and Dainippon Sumitomo Pharma Co., Ltd., an Osaka, Japan-based pharmaceutical company, announced today the intent to change the Sepracor name to Sunovion Pharmaceuticals Inc. in the United States. DSP acquired Sepracor in October 2009 and the name change is planned to occur in anticipation of the one-year anniversary of the acquisition. Sepracor intends to begin officially operating as Sunovion Pharmaceuticals Inc. before the end of 2010.

15 Jul 2010

Type 1 diabetes affects athletic performance, new study finds

A new study led by York University researchers finds that young athletes with Type 1 diabetes may experience a marked decrease in performance as a result of their blood sugar levels.

15 Jul 2010

Cigarette smoking affects entire networks of gene interaction: Research

The effects of smoking cigarettes on gene activity have been investigated in the largest study of its kind. Researchers writing in the open access journal BMC Medical Genomics studied white blood cells taken from 1,240 people to identify 323 unique genes whose expression levels were significantly correlated with smoking behavior.

15 Jul 2010

U.S. District Court dismisses Taro's complaint against Sun and Alkaloida

Sun Pharmaceutical Industries Ltd. today announced that the United States District Court for the Southern District of New York had dismissed in its entirety the complaint filed by Taro Pharmaceutical Industries Ltd. seeking to block the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd., to purchase all outstanding Ordinary Shares of Taro.

15 Jul 2010

Activities of TAT fully consolidated into Geron

Geron Corporation today announced that the activities of TA Therapeutics, its joint venture with Hong Kong University of Science and Technology, are being fully consolidated into Geron.

15 Jul 2010

First Edition: July 15, 2010

Headlines topping today's news include reports about the White House release of new coverage rules for certain screening tests and other types of preventive care, and calls from the GOP for hearings on Berwick's recess appointment to run Medicare and Medicaid top today's news.

15 Jul 2010

Research shows behavioral economic analysis may help understand role of craving in addictions

Just-published research led by a psychologist at the University of Georgia shows that behavioral economic analysis may lead to an improved understanding of craving for alcohol and other drugs. This method of studying how craving alters the way a person values a drug is fairly new, but according to the study, it may well help assess cravings more accurately and contribute to identifying more effective ways to defeat addictions.

15 Jul 2010

St. Luke's Episcopal Hospital ranked among America's elite healthcare institutions

In its annual survey of "America's Best Hospitals," U.S. News & World Report has ranked St. Luke's Episcopal Hospital (SLEH) among the elite healthcare institutions in the nation in five major areas of care. This includes the Texas Heart® Institute (THI) at St. Luke's Episcopal Hospital, listed in the top ten nationally in heart and heart surgery for the 20th consecutive year.

15 Jul 2010

Study looks at trans fat trends in major fast food chains

Five major fast food chains have significantly decreased trans fats in the oils they use to cook food, according to new research from the University of Minnesota School of Public Health.

15 Jul 2010

AHA calls for entries for 2010 Howard L. Lewis Achievement Award

The American Heart Association announces the call for entries for the 2010 Howard L. Lewis Achievement Award, the association's highest honor for health and science reporting.

15 Jul 2010

Dance works all over for health, researcher says

Can elderly Latinos who have limited mobility and face elevated risks of disability dance their way to better health? A University of Illinois at Chicago researcher wants to find out.

15 Jul 2010

Decreased perioperative cerebral oxygenation values linked to poor outcomes after aortic arch surgery

CAS Medical Systems, Inc. today announced that a new study published in The Journal of Thoracic and Cardiovascular Surgery supports the association between decreased perioperative cerebral oxygenation values and poor outcomes after aortic arch surgery.

15 Jul 2010

American Heart Association comments on FDA advisory committee's rosiglitazone recommendations

After two days of hearings, an advisory committee to the U.S. Food and Drug Administration (FDA) recommended that the FDA allow the type 2 diabetes drug rosiglitazone (brand name, Avandia), to stay on the market, but with most committee members suggesting that the label be revised to include increased warnings. Rosiglitazone is one in a class of drugs called thiazolidinediones (TZDs), used to treat type 2 diabetes.

15 Jul 2010

MD Buyline identifies top emerging technologies with highest impact

This release will explain how these important technologies encourage high utilization rates across multiple service lines, bringing value to hospitals. Reimbursement changes and hospital structure enable technology purchases to generate a sequence of changes throughout service lines and dramatically impact the bottom line.

15 Jul 2010

Heart Disease News and Research

Latest Heart Disease News and Research

New findings on macrophage activation can facilitate development of early diagnosis tools

ACTOS offers safety profile regarding risk of CV events in people with type 2 diabetes: Takeda

Glaxo announces a $2.3 billion in legal liability charges

Scientists gather to discuss latest advances in Alzheimer's disease at AAICAD 2010

Practice Fusion API Challenge kicked off

National Jewish Health named #1 respiratory hospital in the nation

Sepracor to change name to Sunovion Pharmaceuticals

Type 1 diabetes affects athletic performance, new study finds

Cigarette smoking affects entire networks of gene interaction: Research

U.S. District Court dismisses Taro's complaint against Sun and Alkaloida

Activities of TAT fully consolidated into Geron

First Edition: July 15, 2010

Research shows behavioral economic analysis may help understand role of craving in addictions

St. Luke's Episcopal Hospital ranked among America's elite healthcare institutions

Study looks at trans fat trends in major fast food chains

AHA calls for entries for 2010 Howard L. Lewis Achievement Award

Dance works all over for health, researcher says

Decreased perioperative cerebral oxygenation values linked to poor outcomes after aortic arch surgery

American Heart Association comments on FDA advisory committee's rosiglitazone recommendations

MD Buyline identifies top emerging technologies with highest impact

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in